Q4 2025 Management View President and CEO Shawn K. Singh highlighted that Vistagen is advancing a pipeline of five ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...

To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of ...

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...

"Transparency is important to us at Wildtype." Wildtype is the third lab-grown meat producer to receive full government ...

The FDA announced a new fast-track approval program for domestic drug developers for projects that are national priorities.

A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy ...

Merck has received approval from the Food and Drug Administration to expand use of its blockbuster drug, Keytruda, to treat ...

Factor XIIa inhibitor Andembry (garadacimab) has been cleared in the US for use in patients aged 12 and over with HAE, which ...

The program will bring together experts from across the FDA for a team-based review, rather than having an application move ...